CE has just printed Q2 results and the immediate market reaction is a mild relief: the stock added 3% on the day and 4% on the week to close at $45.24, with short sellers retreating from positions built ahead of the release.
The sharpest move in the positioning data is the unwinding of the July 28 spike. Short interest surged above 11 million shares that day — likely tactical hedging into the print — before collapsing back to roughly 8.2 million, equal to 7.5% of the free float. That is still a meaningful short book, but the week-on-week decline of more than 10% suggests at least some bears covered into the result rather than pressing. Borrowing costs have eased to 0.43%, down around 9% on the week and 14% over the past month, reinforcing that there is no stress in the lending market. Availability has expanded sharply — at over 1,177% of current short interest, there is abundant capacity on either side of the trade. Options tell the same low-conviction story: the put/call ratio of 0.97 sits almost exactly on its 20-day average, with a z-score barely above zero, suggesting neither a rush to hedge nor any unusual call-side speculation around the earnings catalyst.
The analyst community remains the more meaningful pressure point. The direction of travel on targets has been consistently downward. BMO Capital this morning cut its target again — from $57 to $54 — while holding its Market Perform rating, a day after the print. Morgan Stanley trimmed from $72 to $58 in mid-July. BMO had already dropped from $80 to $57 in early July. The mean price target now sits at $67.50, which implies roughly 49% upside from current levels — a gap that reflects either deep undervaluation or targets that have not fully caught down to where the stock has traded. The bull case centres on a macro recovery in automotive and electronics driving acetyl demand back toward historical norms and EBITDA approaching $2.5 billion. Bears point to acetyl demand in the Western Hemisphere at two-decade lows, persistent softness in Chinese and European auto markets, and a revenue base that declined 2% year-over-year in the most recently reported quarter. Valuation multiples tell their own story: CE trades at a PE of just 7.1x and an EV/EBITDA of roughly 8x, with a price-to-book below 1x — levels that price in a prolonged earnings trough rather than any near-term recovery.
The one previous earnings print with available reaction data adds relevant context. In May, Celanese fell nearly 8% the next day and was still down 7.7% five days later. Today's modest bounce is a different outcome, though the stock remains down roughly 5% over the past month — the relief is real but the longer trend has not reversed.
The key question heading into the coming weeks is whether the steady drip of analyst target reductions pauses now that the print has cleared, or whether the bear case on Western Hemisphere acetyl demand prompts another round of estimate cuts before the next quarterly update.
See the live data behind this article on ORTEX.
Open CE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
